FOXO4-DRI (Proxofim) is manufactured by solid-phase peptide synthesis from synthetic origin, purified by preparative reversed-phase HPLC, and supplied as a white to off-white lyophilized powder at a purity of not less than 98% by HPLC
Q6: Will I regain weight if I stop Regain risk depends on whether habits and body composition were protected during the loss phase
Patients should target 25 to 30 grams of dietary fiber daily, stay above 2 liters of water intake, and consider osmotic laxatives like polyethylene glycol (MiraLax, 17 g daily) if dietary measures fail within five days
if a site faces strict regulations regarding chloride ion discharge, wastewater treatment planning must be conducted in advance
The product is a compounded buccal-dissolve formulation it is not FDA-approved, and the company received an FDA warning letter on February 20, 2026 over labeling and marketing claims